Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2401 - 2408 of 11456 results
Frank Sciame Buys Massive Gold Coast mansion. Now what?
July 29, 2021| News
EXCLUSIVE RIGHTS: Intellectual Property — Patent Damages Deep Dive with Mintz and BDO – Part II of II
July 29, 2021| Podcast| Viewpoint
Combatting Patient Leakage by Directing Physician Referrals: What is Permitted under the Stark Law?
July 29, 2021| Blog| Viewpoint
Higher Education Faces Infrastructure Uncertainty
July 28, 2021| News
In a Rare Rule 11 Sanctions Decision in a Securities Case, The Court Declined to Impose Sanctions Against The Plaintiffs
July 28, 2021| Blog| Viewpoint
Drumbeat Grows for Employers to Mandate COVID Vaccines
July 28, 2021| News
Webinar Recording: COVID-19: An Update for Families and Children as Restrictions Are Eased
July 28, 2021| Webinar| Viewpoint
Mitigating Cybersecurity Risks for Retirement Plans
July 28, 2021| News
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.